Author： Telenti A.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.59, Iss.2, 2000-02, pp. : 171-179
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drug-Resistant Tuberculosis: What are the Treatment Options?
By Albanna Amr S. Menzies Dick
Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. :
Access to resources
Recommend
Prevention and Pharmacovigilance: What Should We Do, What Can We Do?
Drug Safety, Vol. 35, Iss. 2, 2012-02 ,pp. :
Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?
By Nosten F.
CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. :
Pharmacotherapies for Obstructive Sleep Apnoea: Where Are We Now?
Drugs, Vol. 64, Iss. 13, 2004-01 ,pp. :